CHMP5 and COVID-19: In this study, we characterized cellular and humoral immune responses to COVID-19 mRNA vaccination and show that the BNT162b2 mRNA vaccine induces antibody, B-cell, and T-cell responses to Spike antigen in both naive and previously infected children (5-17 years of age).